Reversible Splenial Lesion Syndrome Associated with Encephalitis/encephalopathy Presenting with Great Clinical Heterogeneity

Overview

Journal BMC Neurol

Publisher Biomed Central

Specialty Neurology

Date 2016 Apr 20

PMID 27089920

Citations 24

Authors

Yuanzhao Zhu

Junjun Zheng

Ling Zhang

Zhenguo Zeng

Min Zhu

Xiaobin Li

Xiaoliang Lou

Hui Wan

Daojun Hong

Affiliations

Soon will be listed here.

Abstract

Background: Reversible splenial lesion syndrome (RESLES) is a disorder radiologically characterized by reversible lesion in the splenium of the corpus callosum (SCC). Most of patients with RESLES associated with encephalitis/encephalopathy were identified in Japanese population, but almost no Chinese patients were diagnosed as RESLES associated with encephalitis/encephalopathy.

Methods: Possible patients with reversible isolated SCC lesions were retrieved from January 2012 to July 2015 using keyword "restricted diffusion and isolated SCC lesion" in MRI report system from a large academic center. The clinical, laboratory and radiological data were summarized.

Results: A total of 15 encephalitis/encephalopathy patients (9 males and 6 females) were identified with a reversible isolated SCC lesion. Except for 13 patients with fever symptom, 8 patients also had cold symptoms before the onset of neurological symptoms. The neurological symptoms included headache, vertigo, seizure, disturbance of consciousness, and delirious behavior. Thirteen patients completely recovered within 1 month, but 2 patients who were subjected to mechanical ventilation had persistent neurological deficits. The initial MRI features showed isolated ovoid or extending SCC lesions with homogeneous hyperintense on diffusion weighted imaging (DWI) and decreased apparent diffusion coefficient (ADC) values. The follow-up MRI revealed that isolated SCC lesions with diffuse restriction disappeared at 10 to 32 days after the initial MRI study. Fractional anisotropy map revealed the decreased value of SCC lesion in a severe case with poor prognosis.

Conclusions: RESLES associated with encephalitis/encephalopathy is a reversible syndrome with an excellent prognosis in most patients, while a few patients required ventilator supporting at the early stage might have severe neurological sequelae. Reversible signal changes on DWI and ADC are identified in all patients, but fractional anisotropy values can be decreased in severe patient with neurological sequelae.

Citing Articles

Wang H, Li Y, Liang J, Xue Y, Zhu L, Xiong T Ann Med. 2024; 56(1):2401107.

PMID: 39253859 PMC: 11389624. DOI: 10.1080/07853890.2024.2401107.

Adult-onset of mild encephalitis/encephalopathy with reversible splenial lesion (MERS): case report and systematic review.

Chiara R, Vanessa P, Nazerian P, Gabriele V, Antonio F, Luca M Neurol Sci. 2024; 45(11):5189-5199.

PMID: 38904900 DOI: 10.1007/s10072-024-07627-0.

Reversible Splenial Lesion Syndrome Associated With Dengue Encephalopathy: A Case Report.

Yerremreddy S, Doddapaneni N Cureus. 2023; 15(11):e48109.

PMID: 37920426 PMC: 10619595. DOI: 10.7759/cureus.48109.

Clinico-radiologic subtypes and therapeutic observation of acute Marchiafava-Bignami disease.

Zhang Y, Ran C, Xu C, Li W Sci Rep. 2023; 13(1):18516.

PMID: 37898646 PMC: 10613259. DOI: 10.1038/s41598-023-45431-6.

Neuroimaging in acute infection-triggered encephalopathy syndromes.

Takanashi J, Uetani H Front Neurosci. 2023; 17:1235364.

PMID: 37638320 PMC: 10447893. DOI: 10.3389/fnins.2023.1235364.

References

Sato T, Ushiroda Y, Oyama T, Nakatomi A, Motomura H, Moriuchi H . Kawasaki disease-associated MERS: pathological insights from SPECT findings. Brain Dev. 2011; 34(7):605-8. DOI: 10.1016/j.braindev.2011.09.015. View

Ganapathy S, Ey E, Wolfson B, Khan N . Transient isolated lesion of the splenium associated with clinically mild influenza encephalitis. Pediatr Radiol. 2008; 38(11):1243-5. DOI: 10.1007/s00247-008-0949-z. View

Fuchigami T, Goto K, Hasegawa M, Saito K, Kida T, Hashimoto K . A 4-year-old girl with clinically mild encephalopathy with a reversible splenial lesion associated with rotavirus infection. J Infect Chemother. 2012; 19(1):149-53. DOI: 10.1007/s10156-012-0421-8. View

Miyata R, Tanuma N, Hayashi M, Imamura T, Takanashi J, Nagata R . Oxidative stress in patients with clinically mild encephalitis/encephalopathy with a reversible splenial lesion (MERS). Brain Dev. 2011; 34(2):124-7. DOI: 10.1016/j.braindev.2011.04.004. View

Ka A, Britton P, Troedson C, Webster R, Procopis P, Ging J . Mild encephalopathy with reversible splenial lesion: an important differential of encephalitis. Eur J Paediatr Neurol. 2015; 19(3):377-82. DOI: 10.1016/j.ejpn.2015.01.011. View

Hoshino A, Saitoh M, Oka A, Okumura A, Kubota M, Saito Y . Epidemiology of acute encephalopathy in Japan, with emphasis on the association of viruses and syndromes. Brain Dev. 2011; 34(5):337-43. DOI: 10.1016/j.braindev.2011.07.012. View

Degirmenci E, Degirmenci T, Cetin E, Kiroglu Y . Mild encephalitis/encephalopathy with a reversible splenial lesion (MERS) in a patient presenting with papilledema. Acta Neurol Belg. 2014; 115(2):153-5. DOI: 10.1007/s13760-014-0314-y. View

Polster T, Hoppe M, Ebner A . Transient lesion in the splenium of the corpus callosum: three further cases in epileptic patients and a pathophysiological hypothesis. J Neurol Neurosurg Psychiatry. 2001; 70(4):459-63. PMC: 1737304. DOI: 10.1136/jnnp.70.4.459. View

Hashimoto Y, Takanashi J, Kaiho K, Fujii K, Okubo T, Ota S . A splenial lesion with transiently reduced diffusion in clinically mild encephalitis is not always reversible: A case report. Brain Dev. 2008; 31(9):710-2. DOI: 10.1016/j.braindev.2008.10.005. View

10.

Okamoto T, Sato Y, Yamazaki T, Hayashi A . Clinically mild encephalitis/encephalopathy with a reversible splenial lesion associated with febrile urinary tract infection. Eur J Pediatr. 2013; 173(4):533-6. PMC: 3951960. DOI: 10.1007/s00431-013-2199-9. View

11.

Osuka S, Imai H, Ishikawa E, Matsushita A, Yamamoto T, Nozue H . Mild encephalitis/encephalopathy with a reversible splenial lesion: evaluation by diffusion tensor imaging. Two case reports. Neurol Med Chir (Tokyo). 2011; 50(12):1118-22. DOI: 10.2176/nmc.50.1118. View

12.

Fluss J, Ferey S, Menache-Starobinski C, Delavelle J, Van Bogaert P, Vargas M . Mild influenza-associated encephalopathy/encephalitis with a reversible splenial lesion in a Caucasian child with additional cerebellar features. Eur J Paediatr Neurol. 2009; 14(1):97-100. DOI: 10.1016/j.ejpn.2009.09.007. View

13.

Hara M, Mizuochi T, Kawano G, Koike T, Shibuya I, Ohya T . A case of clinically mild encephalitis with a reversible splenial lesion (MERS) after mumps vaccination. Brain Dev. 2011; 33(10):842-4. DOI: 10.1016/j.braindev.2010.12.013. View

14.

Cho J, Ha S, Han Y, Park S, Hong K, Han J . Mild encephalopathy with reversible lesion in the splenium of the corpus callosum and bilateral frontal white matter. J Clin Neurol. 2009; 3(1):53-6. PMC: 2686937. DOI: 10.3988/jcn.2007.3.1.53. View

15.

Kashiwagi M, Tanabe T, Shimakawa S, Nakamura M, Murata S, Shabana K . Clinico-radiological spectrum of reversible splenial lesions in children. Brain Dev. 2013; 36(4):330-6. DOI: 10.1016/j.braindev.2013.05.007. View

16.

Shankar B, Narayanan R, Muralitharan P, Ulaganathan B . Evaluation of mild encephalitis/encephalopathy with a reversible splenial lesion (MERS) by diffusion-weighted and diffusion tensor imaging. BMJ Case Rep. 2014; 2014. PMC: 4054593. DOI: 10.1136/bcr-2014-204078. View

17.

Fridinger S, Alper G . Defining encephalopathy in acute disseminated encephalomyelitis. J Child Neurol. 2013; 29(6):751-5. DOI: 10.1177/0883073813489732. View

18.

Miya K, Takahashi Y, Mori H . Anti-NMDAR autoimmune encephalitis. Brain Dev. 2013; 36(8):645-52. DOI: 10.1016/j.braindev.2013.10.005. View

19.

Iype M, Ahamed S, Thomas B, Kailas L . Acute encephalopathy with a lesion of the splenium of the corpus callosum--a report of two cases. Brain Dev. 2011; 34(4):322-4. DOI: 10.1016/j.braindev.2011.06.004. View

20.

Dubey D, Sawhney A, Greenberg B, Lowden A, Warnack W, Khemani P . The spectrum of autoimmune encephalopathies. J Neuroimmunol. 2015; 287:93-7. DOI: 10.1016/j.jneuroim.2015.08.014. View